Screener
Novavax NVAX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Novavax’s reported figures.
The source filing: Novavax’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001000694-26-000018
FAQ
- What is Novavax's free cash flow?
- Novavax (NVAX) reported free cash flow of -$73.4M in Q2 2026.
- How has Novavax's free cash flow changed year-over-year?
- Novavax's free cash flow increased by 42.7% year-over-year, from -$127.99M to -$73.4M.
- What is the long-term trend for Novavax's free cash flow?
- Over 2 years (2022 to 2024), Novavax's free cash flow has grown at a -55.4% compound annual growth rate (CAGR), from -$504.99M to -$100.32M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Novavax's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude